Clinical Trial Update: Propagation ANalysis for Arrhythmogenic Conduction Elimination to Prevent Atrial Flutter and Fibrillation (PANACEA-AF)

View source ↗

Summary

A completed clinical trial (PANACEA-AF, NCT03737838) from the University of Chicago evaluating propagation analysis to prevent atrial flutter and atrial fibrill…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Snippet

Sponsor: University of Chicago | Conditions: Atrial Fibrillation | Status: COMPLETED